XS-03
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XS-03, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation [Phase 1, Phase 2]